- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Meihua International Medical Technologies Co Ltd (MHUA)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/06/2026: MHUA (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -60.75% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 14.36M USD | Price to earnings Ratio 1.13 | 1Y Target Price - |
Price to earnings Ratio 1.13 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.85 | 52 Weeks Range 0.25 - 1.47 | Updated Date 06/29/2025 |
52 Weeks Range 0.25 - 1.47 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.4 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 11.19% | Operating Margin (TTM) 16.33% |
Management Effectiveness
Return on Assets (TTM) 5% | Return on Equity (TTM) 7.09% |
Valuation
Trailing PE 1.13 | Forward PE - | Enterprise Value 6349300 | Price to Sales(TTM) 0.15 |
Enterprise Value 6349300 | Price to Sales(TTM) 0.15 | ||
Enterprise Value to Revenue 0.07 | Enterprise Value to EBITDA 0.4 | Shares Outstanding 31904500 | Shares Floating 15734833 |
Shares Outstanding 31904500 | Shares Floating 15734833 | ||
Percent Insiders 49.95 | Percent Institutions 1.06 |
Upturn AI SWOT
Meihua International Medical Technologies Co Ltd
Company Overview
History and Background
Meihua International Medical Technologies Co Ltd (Meihua International) has a history rooted in the medical technology sector. While specific founding dates and detailed early milestones are not readily available in public consolidated records, the company has evolved to focus on the research, development, manufacturing, and sale of medical devices and related products. Its trajectory has involved navigating the complexities of the healthcare industry and adapting to technological advancements.
Core Business Areas
- Medical Devices: Meihua International focuses on the development and production of various medical devices. This segment likely encompasses a range of products used in diagnostic, therapeutic, or surgical procedures. The company aims to address unmet needs in healthcare through innovative solutions.
- Healthcare Solutions: Beyond specific devices, the company may offer broader healthcare solutions, which could include integrated systems, software for medical data management, or services related to the application of their technologies. This segment aims to provide comprehensive support to healthcare providers.
Leadership and Structure
Information regarding the specific leadership team and organizational structure of Meihua International Medical Technologies Co Ltd is not consistently detailed in publicly accessible summaries. Typically, companies of this nature are led by a Board of Directors and a senior executive team responsible for strategy, operations, and financial management.
Top Products and Market Share
Key Offerings
- Description: Meihua International is involved in the production of various medical devices. The exact portfolio can vary, but it generally includes equipment used for diagnosis, treatment, and surgical interventions. Market share data for individual products is not publicly consolidated. Competitors would vary widely depending on the specific device category, including established global medical technology companies and specialized domestic manufacturers.
- Product Name: Specific Medical Devices (e.g., Diagnostic Equipment, Surgical Instruments)
- Description: This segment might include software platforms or integrated systems designed to enhance healthcare delivery, data management, or patient monitoring. Specific revenue figures or market share for these solutions are not readily available. Competitors could include IT companies specializing in healthcare or other medical technology firms offering similar integrated solutions.
- Product Name: Healthcare Technology Solutions
Market Dynamics
Industry Overview
The global medical technology industry is characterized by rapid innovation, increasing demand driven by aging populations and rising healthcare expenditures, and stringent regulatory environments. Key trends include the adoption of digital health solutions, artificial intelligence in diagnostics, and minimally invasive surgical techniques. Competition is intense, with both large multinational corporations and specialized niche players.
Positioning
Meihua International Medical Technologies Co Ltd is positioned as a provider of medical devices and healthcare solutions. Its competitive advantages may stem from its R&D capabilities, manufacturing expertise, and ability to identify specific market needs. However, it faces competition from larger, more established players with greater brand recognition and extensive distribution networks.
Total Addressable Market (TAM)
The total addressable market for medical devices and healthcare solutions is substantial and growing, driven by global health trends and technological advancements. Precise TAM figures for Meihua International's specific product niches are not publicly detailed, but the overall market is valued in the hundreds of billions of dollars. Meihua International's positioning within this TAM depends on its ability to capture market share in its chosen segments through innovation and effective market penetration.
Upturn SWOT Analysis
Strengths
- Research and Development capabilities
- Manufacturing expertise in medical technologies
- Focus on specific niche markets within healthcare
- Potential for agile adaptation to market needs
Weaknesses
- Limited brand recognition compared to established global players
- Potential reliance on key suppliers or distribution channels
- Challenges in scaling operations and global market penetration
- Access to capital for extensive R&D and market expansion
Opportunities
- Growing global demand for advanced medical technologies
- Emerging markets with increasing healthcare spending
- Strategic partnerships and collaborations
- Technological advancements enabling new product development (e.g., AI, IoT in healthcare)
Threats
- Intense competition from established medical device companies
- Stringent and evolving regulatory requirements
- Rapid technological obsolescence of products
- Economic downturns impacting healthcare budgets
- Intellectual property challenges and patent infringements
Competitors and Market Share
Key Competitors
- Medtronic plc (MDT)
- Abbott Laboratories (ABT)
- Johnson & Johnson (JNJ)
- Siemens Healthineers AG (SEMHF)
Competitive Landscape
Meihua International faces significant competition from large, diversified medical device manufacturers with substantial R&D budgets, extensive global sales forces, and established brand loyalty. Its advantages might lie in specialization, agility, and potentially cost-competitiveness in certain product categories. Disadvantages include brand recognition, market access, and the scale of operations compared to industry giants.
Growth Trajectory and Initiatives
Historical Growth: Meihua International's historical growth trajectory is not clearly defined by easily accessible public data. Companies in the medical technology space typically aim for growth through new product launches, market expansion, and strategic partnerships.
Future Projections: Specific future growth projections for Meihua International Medical Technologies Co Ltd from analyst estimates are not widely publicized. Projections for the broader medical technology industry are generally positive, driven by technological advancements and demographic trends.
Recent Initiatives: Recent strategic initiatives would likely involve R&D investments in new technologies, expansion into new geographic markets, potential mergers or acquisitions, and efforts to strengthen distribution networks.
Summary
Meihua International Medical Technologies Co Ltd operates in the dynamic and competitive medical technology sector. Its core business revolves around medical devices and healthcare solutions, aiming to address evolving healthcare needs. While specific financial and market share data is limited, the company likely faces challenges from established global players, yet has opportunities in technological innovation and growing healthcare demand. Continued investment in R&D and strategic market penetration will be key to its success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- General industry reports for the medical technology sector
- Publicly available financial databases (limited for specific company)
- Company press releases and official filings (if available)
Disclaimers:
This analysis is based on publicly available information, which may be limited or not fully consolidated. Specific financial data and market share percentages for Meihua International Medical Technologies Co Ltd are not extensively detailed. This information should not be considered financial advice, and investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Meihua International Medical Technologies Co Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2022-02-16 | CEO & Director Mr. Wang Xin | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 619 | Website https://www.meihuamed.com |
Full time employees 619 | Website https://www.meihuamed.com | ||
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; Class II products, such as disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation, medical masks, anal bags, and suction connecting tube, etc.; and Class III disposable medical devices, such as disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. It also offers disposable plastic baby bottles, NB/PSN rubber covers and 8.2mL folded spoons for tools and containers, etc.; Class II 6866 medical polymer materials and products, including transfusion equipment and pipelines, endotracheal intubation for respiratory anesthesia or ventilation; and medical x-ray films and multi-functional self-extracting X-ray film machines. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

